14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PBYI
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Puma Biotechnology Inc stock price on Monday which ended trading at $4.62
(Updated on May 06, 2024)

Sell candidate since May 01, 2024 Loss -6.67% PDF

The Puma Biotechnology Inc stock price fell by -4.94% on the last day (Monday, 6th May 2024) from $4.86 to $4.62. During the last trading day the stock fluctuated 12.06% from a day low at $4.36 to a day high of $4.88. The price has fallen in 5 of the last 10 days and is down by -10.64% for this period. Volume has increased on the last day by 195 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 583 thousand shares were bought and sold for approximately $2.70 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -19.54% during the next 3 months and, with a 90% probability hold a price between $2.82 and $4.87 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PBYI Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, March 19, 2024, and so far it has risen 7.44%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Puma Biotechnology Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.93 and $5.18. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Puma Biotechnology Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.30. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.525 between high and low, or 12.06%. For the last week, the stock has had daily average volatility of 7.17%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PBYI) For The Upcoming Trading Day Of Tuesday 7th

For the upcoming trading day on Tuesday, 7th we expect Puma Biotechnology Inc to open at $4.62, and during the day (based on 14 day Average True Range), to move between $4.28 and $4.96, which gives a possible trading interval of +/-$0.336 (+/-7.27%) up or down from last closing price. If Puma Biotechnology Inc takes out the full calculated possible swing range there will be an estimated 14.54% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.66 (0.87%) than the support at $4.30 (6.93%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Puma Biotechnology Inc stock A Buy?

Puma Biotechnology Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.246 Sell Candidate Unchanged

Predicted Opening Price for Puma Biotechnology Inc of Tuesday, May 7, 2024

Fair opening price May 7, 2024 Current price
$4.62 ( 0.0361%) $4.62

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PBYI

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.14 11.33 %
R2 4.94 6.99 %
R1 4.82 4.30 %
Current price: 4.62
Support S1 4.42 -4.38 %
S2 4.29 -7.06 %
S3 4.09 -11.40 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.35 15.80 %
R2 5.33 15.37 %
R1 4.66 0.87 %
Current price 4.62
Support S1 4.30 -6.93%
S2 0 .
S3 0 .

FAQ

What is the symbol for Puma Biotechnology Inc Stock and on which exchange is it traded?
The symbol for Puma Biotechnology Inc is PBYI and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Puma Biotechnology Inc Stock?
Puma Biotechnology Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Puma Biotechnology Inc Stock?
Puma Biotechnology Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Puma Biotechnology Inc Stock.

What's the current price of Puma Biotechnology Inc Stock?
As of the end of day on the May 06, 2024, the price of an Puma Biotechnology Inc (PBYI) share was $4.62.

What is the 52-week high and low for Puma Biotechnology Inc Stock?
The 52-week high for Puma Biotechnology Inc Stock is $95.57 and the 52-week low is $69.42.

What is the market capitalization of Puma Biotechnology Inc Stock?
As of the May 06, 2024, the market capitalization of Puma Biotechnology Inc is 222.863M.

When is the next earnings date for Puma Biotechnology Inc?
The upcoming earnings date for Puma Biotechnology Inc is Aug 01, 2024.
Click to get the best stock tips daily for free!

About Puma Biotechnology Inc

Puma Biotechnology Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advance... PBYI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT